RIGL icon

Rigel Pharmaceuticals
RIGL

Overview Fund Activity

162 hedge funds and large institutions have $365M invested in Rigel Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 43 increasing their positions, 55 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
162
Holders Change
-1
Holders Change %
-0.61%
% of All Funds
2.5%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
26
Increased
43
Reduced
55
Closed
26
Calls
$1.08M
Puts
$1.19M
Net Calls
-$113K
Net Calls Change
-$543K

Top Buyers

1
GPP
1
Great Point Partners
Connecticut
$13.3M
2
LCM
2
Laurion Capital Management
New York
$7.91M
3
Citadel Advisors
3
Citadel Advisors
Florida
$3.75M
4
Hudson Bay Capital Management
4
Hudson Bay Capital Management
Connecticut
$10.6M
5
Walleye Capital
5
Walleye Capital
New York
$1.93M

Top Sellers

1
IAM
1
Ion Asset Management
Israel
$0
2
TA
2
Tamarack Advisers
California
$11.9M
3
Two Sigma Advisers
3
Two Sigma Advisers
New York
$1.5M
4
Fidelity Investments
4
Fidelity Investments
Massachusetts
$65.1M
5
RCMNY
5
Rubric Capital Management (New York)
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
MAM
176
Meeder Asset Management
Ohio
– -$11K -301 Closed
CAC
177
Cowen and Company
New York
– -$9K -239 Closed
RE
178
RBC Europe
United Kingdom
– -$5.45K -150 Closed
US Bancorp
179
US Bancorp
Minnesota
– -$4K -99 Closed
TWA
180
TCI Wealth Advisors
Arizona
– -$3K -70 Closed
JPLA
181
Joseph P. Lucia & Associates
New York
– -$1K -15 Closed
4 5 6 7
8